Biochem/physiol Actions
Tandospirone is a partial agonist at 5HT1A receptors. It significantly reduces haloperidol-induced bradykinesia in a dose-dependent manner. The potency of tandospirone is equal to that of buspirone and approximate half that of diazepam. The potency of tandospirone as a dopamine antagonistic is less than 1/4 that of buspirone.
Features and Benefits
This compound was developed by Dainippon Sumitomo. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 51171822
- Condition:
- New
- HazmatClass:
- No
- MPN:
- T6704-5MG
- CAS:
- 87760-53-0
akash.verma@cenmed.com
(732) 447-1115





